Journament

Keyword Connections - vaccines Keywords

Connection Type	Connection
Journals	Organic & biomolecular chemistry International journal of pharmaceutics Physical chemistry chemical physics : PCCP BMC public health malaria journal molecular pharmaceutics Frontiers in immunology Nature scientific american Biomolecules The American journal of forensic medicine and pathology technology and culture public understanding of science (bristol, england) Vaccine Vaccine: X BMJ global health european geriatric medicine La Clinica terapeutica canada communicable disease report = releve des maladies transmissibles au canada the journal of allergy and clinical immunology xi bao yu fen zi mian yi xue za zhi = chinese journal of cellular and molecular immunology health education & behavior : the official publication of the society for public health education revista espanola de quimioterapia : publicacion oficial de la sociedad espanola de quimioterapia expert opinion on biological therapy Drug discovery today virusdisease biologicals : journal of the international association of biological standardization
Research Groups	No Research Group Connected
Bibliographies	[1] Do health care providers trust product monograph information regarding use of vaccines in pregnancy? A qualitative study. [2] Improving nutrition and physical activity environments of family child care homes: the rationale, design and study protocol of the 'Healthy Start/Comienzos Sanos' cluster randomized trial. [3] Vaccination programs for older adults in an era of demographic change. [4] Applications of alginate microspheres in therapeutics delivery and cell culture: Past, present and future. [5] An observational study of university students of healthcare area: knowledge, attitudes and behaviour towards vaccinations. [6] Image of the new vaccination obligation through the media. [7] Factors influencing basic vaccination coverage in Myanmar: secondary analysis of 2015 Myanmar demographic and health survey data. [8] Tuberculosis vaccine finds an improved route. [9] Prevention of tuberculosis in macaques after intravenous BCG immunization. [10] [ASAP1 knockdown reduces migration of RAW264.7 cells infected with Mycobacterium tuberculosis]. [11] Global harmonization of vaccine testing requirements: Making elimination of the ATT and TABST a concrete global achievement. [12] The up-to-date role of biologics for the treatment of chronic lymphocytic leukemia. [13] Recommendations for the diagnosis and treatment of Clostridioides difficile infection: An official clinical practice guideline of the Spanish Society of Chemotherapy (SEQ), Spanish Society of Internal Medicine (SEMI) and the working group of Postoperative Infection of the Spanish Society of Anesthesia and Reanimation (SEDAR). [14] Progress in the Use of Antisense Oligonucleotides for Vaccine Improvement. [15] Fear and Derision: A Quantitative Content Analysis of Provaccine and Antivaccine Internet Memes. [16] Eosinophil Responses During COVID-19 Infections and Coronavirus Vaccination. [17] Coronavirus as silent killer: recent advancement to pathogenesis, therapeutic strategy and future perspectives. [18] Transcriptome Analysis Identifies Immune Markers Related to Visceral Leishmaniasis Establishment in the Experimental Model of BALB/c Mice. [19] Community-acquired bacterial meningitis [20] Heterotypic immunity against vaccinia virus in an HLA-B*07:02 transgenic mousepox infection model [21] Do Antenatal Parasite Infections Devalue Childhood Vaccination? [22] Does the use of personal electronic health records increase vaccine uptake? A systematic review. [23] a pandemic in disguise: zika virus vaccine development and counteractive measures analysis [24] kaiser permanente vaccine study center: highlights of 2009–2012 [25] immunotherapeutic advancements for glioblastoma [26] encuesta nacional de cobertura de vacunación (influenza, neumococo y tétanos) en adultos mayores de 60 años en méxico national survey of vaccination coverage (influenza, pneumococcus and tetanus) in mexican population of 60 years of age and older [27] respiratory tract deposition and distribution pattern of microparticles in mice using different pulmonary delivery techniques [28] perspectives on reprogramming cancer-associated dendritic cells for antitumor therapies [29] Novel Formaldehyde-Induced Modifications of Lysine Residue Pairs in Peptides and Proteins: Identification and Relevance to Vaccine Development. [30] Deciphering the chemical instability of sphaeropsidin A under physiological conditions - degradation studies and structural elucidation of the major metabolite. [31] exploiting synergy: immune-based combinations in the treatment of prostate cancer [32] the influence of delivery vectors on hiv vaccine efficacy [33] pandemic h1n1 influenza infection and vaccination in humans induces cross-protective antibodies that target the hemagglutinin stem [34] a dead-end host: is there a way out? a position piece on the ebola virus outbreak by the international union of immunology societies [35] vacinação dos viajantes: experiência do ambulatório dos viajantes do hospital das clínicas da faculdade de medicina da universidade de são paulo travelers' vaccinations: experience from the travelers' clinic of hospital das clínicas, university of são paulo school of medicine [36] human papillomavirus and vaccination in cervical cancer [37] tick vaccines and the control of tick-borne pathogens [38] cancer immunotherapy: lights and shadows [39] anti-tumor immunity in head and neck cancer: understanding the evidence, how tumors escape and immunotherapeutic approaches [40] helicobacter pylori caga: from pathogenic mechanisms to its use as an anti-cancer vaccine [41] impacto de la lactancia materna en la vacunación infantil effect of the breastfeeding on the infant vaccination [42] a model to study the impact of polymorphism driven liver-stage immune evasion by malaria parasites, to help design effective cross-reactive vaccines [43] vaccination against q fever for biodefense and public health indications [44] preventive vaccines for cervical cancer vacunas para prevenir el cáncer cervical [45] The reactive vaccination campaign against cholera emergency in camps for internally displaced persons, Borno, Nigeria, 2017: a two-stage cluster survey. [46] Homicide-Suicide: A Homicidal Asphyxiation Misinterpreted as a Gunshot Wound at the Scene. [47] To fight tuberculosis, fund basic research [48] Rabies Post-Exposure Prophylaxis in the Philippines: Health Status of Patients Having Received Purified Equine F(ab')2 Fragment Rabies Immunoglobulin (Favirab) [49] ViralVacDB: A manually curated repository of viral vaccines. [50] CONTENT REVIEW OF VACCINES AND VACCINATION RELATED NEWS IN INTERNET NEWSPAPERS [51] Meningococcal conjugate vaccines: optimizing global impact [52] Review of oral cholera vaccines: efficacy in young children [53] CONTENT REVIEW OF VACCINES AND VACCINATION RELATED NEWS IN INTERNET NEWSPAPERS [54] CONTENT REVIEW OF VACCINES AND VACCINATION RELATED NEWS IN INTERNET NEWSPAPERS [55] Meningococcal conjugate vaccines: optimizing global impact [56] Review of oral cholera vaccines: efficacy in young children [57] Acceptability and Feasibility of Delivering Pentavalent Vaccines in a Compact, Prefilled, Autodisable Device in Vietnam and Senegal. [58] At the bench: Engineering the next generation of cancer vaccines. [59] "You need to do your research": Vaccines, contestable science, and maternal epistemology. [60] The art of partnerships for vaccines. [61] The costs of delivering vaccines in low- and middle-income countries: Findings from a systematic review. [62] A Scoping Review of Investment Cases for Vaccines and Immunization Programs. [63] A systematic review of immunogenicity, clinical efficacy and safety of human papillomavirus vaccines in people living with the human immunodeficiency virus. [64] Increased Valency of Conserved-mosaic Vaccines Enhances the Breadth and Depth of Epitope Recognition. [65] Current status and future prospects for the development of substance abuse vaccines. [66] Combined use of inactivated and oral poliovirus vaccines in refugee camps and surrounding communities - Kenya, December 2013. [67] Workshop report: Experimental animal models for universal influenza vaccines. [68] A comparative study of live attenuated F strain-derived Mycoplasma gallisepticum vaccines. [69] A combinatorial approach to the design of vaccines. [70] High performance of rapid influenza diagnostic test and variable effectiveness of influenza vaccines in Mexico. [71] Protective immunity against influenza virus challenge by norovirus P particle-M2e and HA2-AtCYN vaccines in chickens. [72] Procurement of Category 2 Vaccines in China. [73] Vacinas meningocócicas conjugadas: eficácia e novas combinações Meningococcal conjugate vaccines: efficacy and new combinations [74] Erratum: Recent mechanistic insights on glycoconjugate vaccines and future perspectives (ACS Chemical Biology (2013) 8 (1653-1663) DOI: 10.1021/cb400423g) [75] Comparison of serum and salivary antibodies in children vaccinated with oral live or parenteral inactivated poliovirus vaccines of different antigen concentrations. [76] Has the public lost confidence in vaccines because of a vaccine scandal in China. [77] A social justice perspective on access to human rabies vaccines [78] Erratum to: System immunology-based identification of blood transcriptional modules correlating to antibody responses in sheep (npj Vaccines, (2018), 3, 1, (41), 10.1038/s41541-018-0078-0) [79] Do health care providers trust product monograph information regarding use of vaccines in pregnancy? A qualitative study. [80] Perception of mandatory infant vaccines and trust in vaccination among first-year healthcare students: An opportunity window for the training of future healthcare workers. [81] Does improving maternal knowledge of vaccines impact infant immunization rates? A community-based randomized-controlled trial in Karachi, Pakistan [82] Monophosphoryl-Lipid A (MPLA) is an Efficacious Adjuvant for Inactivated Rabies Vaccines. [83] An overview of biodegradable nanomaterials and applications in vaccines. [84] Learning from epidemiological, clinical, and immunological studies on Mycobacterium africanum for improving current understanding of host–pathogen interactions, and for the development and evaluation of diagnostics, host-directed therapies, and vaccines for tuberculosis [85] Obstacles to developing vaccines for the Third World. [86] Evaluation of novel inactivated vaccines for the SAT 1, SAT 2 and SAT 3 serotypes of foot-and-mouth disease in pigs. [87] How Can the Typhoid Fever Surveillance in Africa and the Severe Typhoid Fever in Africa Programs Contribute to the Introduction of Typhoid Conjugate Vaccines? [88] The Severe Typhoid Fever in Africa Program Highlights the Need for Broad Deployment of Typhoid Conjugate Vaccines [89] Exploring the relationship between newspaper coverage of vaccines and childhood vaccination rates in Spain. [90] Effectiveness, immunogenicity, and safety of influenza vaccines with MF59 adjuvant in healthy people of different age groups: A systematic review and meta-analysis. [91] Pharmacists' impact on older adults' access to vaccines in the United States. [92] Estimated cost-effectiveness and burden of disease associated with quadrivalent cell-based and egg-based influenza vaccines in Spain. [93] Safety and Impact on Training of the Influenza Vaccines in Elite Athletes Participating in the Rio 2016 Olympics. [94] Fighting flu: the importance of vaccines in rheumatic disease [95] Current challenges: from the path of “original antigenic sin” towards the development of universal flu vaccines: Flu vaccine efficacy encounters significant hurdles from pre-existing immunity of the host suggesting assessment of host immunity before vaccination [96] Searching for Improved Flu Vaccines-The Time Is Now [97] Antibiotics can impede flu vaccines [98] Frequently asked questions about flu vaccines: The IntoVac responses [99] Neutrinos, flu vaccines and Fukushima ruling [100] Prospective cohort studies to evaluate the safety and immunogenicity of the 2013, 2014, and 2015 seasonal influenza vaccines produced by instituto Butantan [101] Cost of production of live attenuated dengue vaccines: A case study of the Instituto Butantan, Sao Paulo, Brazil